ArticleBioactive materials2027
Quercetin-derived carbon dots-modified ZIF-8 and M2 macrophage-derived migrasomes-functionalized microenvironment-responsive nanocomposite hydrogel for osteoporotic bone defects regeneration.
Article in Bioactive materials, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The impaired regenerative capacity of osteoporotic individuals poses a significant challenge to the repair of bone defects. In the osteoporotic microenvironment, low pH, excessive reactive oxygen species (ROS), and chronic inflammation create a self-perpetuating vicious cycle that impedes healing. However, conventional therapies fail to sustainably improve the damaged microenvironment. Here, a pH/ROS dual responsive nanocomposite hydrogel (Z-QCDs@M2-Migs@OHA-PP) was developed based on oxidized hyaluronic acid (OHA), phenylboronic acid-grafted ε-polylysine (PP), quercetin-derived carbon dots (QCDs) loaded ZIF-8 (Z-QCDs) and M2 macrophage-derived migrasomes (M2-Migs), which possesses intrinsic antioxidant and osteogenic differentiation-promoting capabilities. Due to the presence of dynamic. Schiff base bonds and boronate bonds, the hydrogel exhibited injectability and pH/ROS dual responsiveness. OHA-PP releases Z-QCDs and M2-Migs on demand in response to changes in pH and ROS levels. Z-QCDs exhibit strong antioxidant and nanozyme activity, capable of scavenging ROS, suppressing inflammatory responses, and promoting M2 macrophage polarization. Furthermore, the introduction of M2-Migs as an osteogenic activator further enhances the capacity for osteogenic differentiation. Transcriptomic and Western blot analyses revealed that the hydrogel promotes osteogenic differentiation by activating the PI3K-AKT signaling pathway. In a mouse osteoporotic bone defect model, the nanocomposite hydrogel effectively inhibited ferroptosis, modulated inflammation, and promoted new bone formation. Therefore, this hydrogel system, which combines therapeutic rationale with microenvironmental regulation, offers a promising strategy for the regeneration of osteoporotic bone defects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.